Prevalença estandarditzada
Evolució temporal de la prevalença estandarditzada per edat i sexe en funció dels grups de fragilitat per sexe, edat i Regió Sanitària.
El grup de No fràgil incluo Robust i Prefràgil.
El grup de Fràgil inclou Fragilitat moderada i Fragilitat severa.
General
2 grups de fragilitat
| No fràgil (0 - 8) |
1,246,677 (89.5%) |
1,249,321 (88.2%) |
1,254,038 (86.9%) |
1,271,004 (87.1%) |
1,312,783 (85.7%) |
| Fràgil (>9) |
168,966 (10.5%) |
190,208 (11.8%) |
211,274 (13.1%) |
208,820 (12.9%) |
251,828 (14.3%) |
4 grups de fragilitat
| Robust (0 - 4) |
770,643 (56.1%) |
764,834 (54.7%) |
760,555 (53.1%) |
780,597 (53.8%) |
797,479 (52.7%) |
| Prefràgil (5 - 8) |
476,034 (33.4%) |
484,487 (33.6%) |
493,483 (33.8%) |
490,407 (33.3%) |
515,304 (33.0%) |
| Fragilitat moderada (9 - 11) |
124,229 (8.1%) |
135,540 (8.7%) |
146,256 (9.4%) |
144,709 (9.2%) |
167,379 (9.9%) |
| Fragilitat severa (>12) |
44,737 (2.5%) |
54,668 (3.1%) |
65,018 (3.7%) |
64,111 (3.7%) |
84,449 (4.4%) |
Prevalença estandarditzada per sexe
2 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
113,792 (12.4%) |
127,230 (13.8%) |
140,793 (15.3%) |
139,469 (15.2%) |
165,370 (16.6%) |
55,174 (8.0%) |
62,978 (9.1%) |
70,481 (10.1%) |
69,351 (9.9%) |
86,458 (11.3%) |
| No fràgil (0 - 8) |
695,603 (87.6%) |
694,384 (86.2%) |
694,337 (84.7%) |
703,073 (84.8%) |
721,329 (83.4%) |
551,074 (92.0%) |
554,937 (90.9%) |
559,701 (89.9%) |
567,931 (90.1%) |
591,454 (88.7%) |
4 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
414,743 (53.1%) |
410,812 (51.6%) |
407,536 (50.1%) |
418,781 (50.8%) |
425,863 (49.8%) |
355,900 (60.1%) |
354,022 (58.7%) |
353,019 (57.1%) |
361,816 (57.7%) |
371,616 (56.4%) |
| Prefràgil (5 - 8) |
280,860 (34.5%) |
283,572 (34.6%) |
286,801 (34.5%) |
284,292 (34.0%) |
295,466 (33.6%) |
195,174 (31.8%) |
200,915 (32.2%) |
206,682 (32.8%) |
206,115 (32.4%) |
219,838 (32.3%) |
| Fragilitat moderada (9 - 11) |
82,046 (9.4%) |
88,678 (10.0%) |
95,203 (10.8%) |
94,266 (10.6%) |
107,030 (11.2%) |
42,183 (6.3%) |
46,862 (7.0%) |
51,053 (7.5%) |
50,443 (7.4%) |
60,349 (8.1%) |
| Fragilitat severa (>12) |
31,746 (3.0%) |
38,552 (3.8%) |
45,590 (4.5%) |
45,203 (4.6%) |
58,340 (5.4%) |
12,991 (1.7%) |
16,116 (2.1%) |
19,428 (2.6%) |
18,908 (2.5%) |
26,109 (3.2%) |
Prevalença estandarditzada per edat
2 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
8,416 (2.1%) |
9,468 (2.3%) |
10,899 (2.7%) |
11,092 (2.7%) |
12,841 (3.0%) |
14,539 (3.8%) |
16,832 (4.4%) |
19,290 (4.9%) |
18,654 (4.9%) |
21,468 (5.6%) |
| No fràgil (0 - 8) |
374,925 (97.9%) |
371,569 (97.7%) |
372,603 (97.3%) |
380,358 (97.3%) |
390,557 (97.0%) |
322,843 (96.2%) |
332,717 (95.6%) |
336,508 (95.1%) |
334,659 (95.1%) |
340,623 (94.4%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
19,386 (7.2%) |
23,256 (8.1%) |
28,555 (9.1%) |
27,667 (8.7%) |
32,789 (9.8%) |
48,863 (19.5%) |
51,867 (21.7%) |
53,087 (24.4%) |
52,436 (23.8%) |
57,350 (25.8%) |
| No fràgil (0 - 8) |
216,159 (92.8%) |
228,877 (91.9%) |
248,950 (90.9%) |
252,953 (91.3%) |
266,871 (90.2%) |
174,997 (80.5%) |
161,510 (78.3%) |
144,235 (75.6%) |
150,536 (76.2%) |
149,137 (74.2%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
46,140 (27.6%) |
52,333 (30.7%) |
57,934 (33.3%) |
56,794 (33.4%) |
68,392 (36.7%) |
24,515 (33.4%) |
28,103 (37.6%) |
31,555 (41.1%) |
32,057 (41.4%) |
43,191 (46.4%) |
| No fràgil (0 - 8) |
104,764 (72.4%) |
103,068 (69.3%) |
100,615 (66.7%) |
100,225 (66.6%) |
105,441 (63.3%) |
41,809 (66.6%) |
40,523 (62.4%) |
40,011 (58.9%) |
40,914 (58.6%) |
45,483 (53.6%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
7,107 (35.0%) |
8,349 (38.5%) |
9,954 (44.2%) |
10,120 (43.9%) |
15,797 (49.2%) |
| No fràgil (0 - 8) |
11,180 (65.0%) |
11,057 (61.5%) |
11,116 (55.8%) |
11,359 (56.1%) |
14,671 (50.8%) |
4 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
291,126 (76.9%) |
286,405 (76.1%) |
284,760 (75.1%) |
293,556 (75.7%) |
298,862 (74.9%) |
221,623 (67.5%) |
224,949 (65.9%) |
223,884 (64.2%) |
226,380 (65.1%) |
228,441 (64.1%) |
| Prefràgil (5 - 8) |
83,799 (21.0%) |
85,164 (21.6%) |
87,843 (22.2%) |
86,802 (21.6%) |
91,695 (22.1%) |
101,220 (28.7%) |
107,768 (29.7%) |
112,624 (30.8%) |
108,279 (30.0%) |
112,182 (30.3%) |
| Fragilitat moderada (9 - 11) |
7,345 (1.8%) |
8,213 (2.0%) |
9,273 (2.3%) |
9,480 (2.3%) |
10,744 (2.5%) |
12,320 (3.3%) |
14,008 (3.7%) |
15,842 (4.1%) |
15,305 (4.0%) |
17,350 (4.5%) |
| Fragilitat severa (>12) |
1,071 (0.2%) |
1,255 (0.3%) |
1,626 (0.4%) |
1,612 (0.4%) |
2,097 (0.5%) |
2,219 (0.5%) |
2,824 (0.7%) |
3,448 (0.8%) |
3,349 (0.8%) |
4,118 (1.0%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
128,084 (56.6%) |
133,623 (55.1%) |
142,044 (53.0%) |
147,005 (53.9%) |
153,168 (52.6%) |
70,509 (33.2%) |
63,385 (31.2%) |
55,537 (29.4%) |
59,269 (30.1%) |
58,460 (29.2%) |
| Prefràgil (5 - 8) |
88,075 (36.1%) |
95,254 (36.8%) |
106,906 (37.8%) |
105,948 (37.4%) |
113,703 (37.6%) |
104,488 (47.3%) |
98,125 (47.1%) |
88,698 (46.2%) |
91,267 (46.1%) |
90,677 (45.0%) |
| Fragilitat moderada (9 - 11) |
15,607 (5.8%) |
18,446 (6.5%) |
22,163 (7.1%) |
21,580 (6.8%) |
25,013 (7.5%) |
36,002 (14.8%) |
37,098 (15.9%) |
36,819 (17.4%) |
36,589 (17.0%) |
38,816 (17.8%) |
| Fragilitat severa (>12) |
3,779 (1.4%) |
4,810 (1.6%) |
6,392 (2.0%) |
6,087 (1.9%) |
7,776 (2.2%) |
12,861 (4.6%) |
14,769 (5.8%) |
16,268 (6.9%) |
15,847 (6.8%) |
18,534 (7.9%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
39,475 (26.4%) |
37,558 (24.7%) |
35,893 (23.1%) |
35,857 (23.3%) |
37,319 (22.0%) |
15,475 (22.9%) |
14,660 (21.1%) |
14,277 (19.7%) |
14,338 (19.1%) |
15,882 (17.4%) |
| Prefràgil (5 - 8) |
65,289 (46.0%) |
65,510 (44.6%) |
64,722 (43.7%) |
64,368 (43.2%) |
68,122 (41.3%) |
26,334 (43.7%) |
25,863 (41.2%) |
25,734 (39.2%) |
26,576 (39.5%) |
29,601 (36.2%) |
| Fragilitat moderada (9 - 11) |
31,759 (20.1%) |
34,673 (21.5%) |
36,978 (22.2%) |
36,181 (22.2%) |
41,798 (23.4%) |
16,351 (23.9%) |
17,769 (25.6%) |
19,209 (27.1%) |
19,444 (26.5%) |
24,577 (28.0%) |
| Fragilitat severa (>12) |
14,381 (7.5%) |
17,660 (9.2%) |
20,956 (11.1%) |
20,613 (11.2%) |
26,594 (13.3%) |
8,164 (9.5%) |
10,334 (12.0%) |
12,346 (14.0%) |
12,613 (14.9%) |
18,614 (18.4%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
4,351 (22.0%) |
4,254 (20.6%) |
4,160 (18.6%) |
4,192 (18.8%) |
5,347 (16.6%) |
| Prefràgil (5 - 8) |
6,829 (43.0%) |
6,803 (40.9%) |
6,956 (37.2%) |
7,167 (37.3%) |
9,324 (34.2%) |
| Fragilitat moderada (9 - 11) |
4,845 (25.7%) |
5,333 (26.6%) |
5,972 (29.2%) |
6,130 (28.8%) |
9,081 (30.6%) |
| Fragilitat severa (>12) |
2,262 (9.3%) |
3,016 (12.0%) |
3,982 (15.0%) |
3,990 (15.1%) |
6,716 (18.6%) |
Prevalença estandarditzada per Regió Sanitaria
2 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
1,332 (8.4%) |
1,492 (9.4%) |
1,678 (10.7%) |
1,633 (10.5%) |
2,075 (12.2%) |
116,095 (12.4%) |
130,563 (13.7%) |
145,180 (15.1%) |
143,161 (14.7%) |
172,021 (16.1%) |
| No fràgil (0 - 8) |
12,515 (91.6%) |
12,536 (90.6%) |
12,523 (89.3%) |
12,584 (89.5%) |
13,011 (87.8%) |
812,329 (87.6%) |
813,742 (86.3%) |
816,457 (84.9%) |
827,103 (85.3%) |
852,916 (83.9%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
8,457 (8.3%) |
9,656 (9.3%) |
10,919 (10.4%) |
10,978 (10.2%) |
13,320 (11.3%) |
12,794 (11.8%) |
14,479 (13.2%) |
16,088 (14.8%) |
15,676 (14.5%) |
19,119 (16.2%) |
| No fràgil (0 - 8) |
97,407 (91.7%) |
98,627 (90.7%) |
99,860 (89.6%) |
101,958 (89.8%) |
106,492 (88.7%) |
88,420 (88.2%) |
88,419 (86.8%) |
88,274 (85.2%) |
88,901 (85.5%) |
91,767 (83.8%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
16,004 (10.1%) |
17,997 (11.4%) |
19,828 (12.5%) |
19,612 (12.2%) |
23,953 (13.5%) |
9,940 (12.6%) |
11,130 (14.1%) |
12,169 (15.5%) |
12,139 (15.5%) |
14,547 (17.0%) |
| No fràgil (0 - 8) |
138,332 (89.9%) |
138,908 (88.6%) |
140,154 (87.5%) |
142,993 (87.8%) |
148,352 (86.5%) |
62,207 (87.4%) |
61,827 (85.9%) |
61,622 (84.5%) |
62,195 (84.5%) |
64,048 (83.0%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
4,344 (10.1%) |
4,891 (11.3%) |
5,412 (12.6%) |
5,621 (12.9%) |
6,793 (14.2%) |
| No fràgil (0 - 8) |
35,467 (89.9%) |
35,262 (88.7%) |
35,148 (87.4%) |
35,270 (87.1%) |
36,197 (85.8%) |
4 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
7,987 (60.6%) |
7,889 (58.7%) |
7,704 (56.2%) |
7,771 (56.2%) |
7,974 (54.9%) |
496,616 (53.7%) |
491,636 (52.3%) |
487,674 (50.8%) |
500,198 (51.7%) |
509,547 (50.6%) |
| Prefràgil (5 - 8) |
4,528 (31.0%) |
4,647 (31.9%) |
4,819 (33.1%) |
4,813 (33.3%) |
5,037 (32.9%) |
315,713 (33.9%) |
322,106 (34.0%) |
328,783 (34.1%) |
326,905 (33.6%) |
343,369 (33.3%) |
| Fragilitat moderada (9 - 11) |
1,043 (6.6%) |
1,139 (7.2%) |
1,251 (8.0%) |
1,215 (7.9%) |
1,491 (8.9%) |
83,615 (8.9%) |
91,318 (9.6%) |
98,797 (10.2%) |
97,905 (10.0%) |
112,795 (10.6%) |
| Fragilitat severa (>12) |
289 (1.8%) |
353 (2.2%) |
427 (2.7%) |
418 (2.7%) |
584 (3.3%) |
32,480 (3.5%) |
39,245 (4.1%) |
46,383 (4.8%) |
45,256 (4.7%) |
59,226 (5.5%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
68,581 (64.1%) |
69,250 (63.2%) |
69,858 (62.1%) |
71,853 (62.7%) |
74,397 (61.7%) |
52,076 (52.9%) |
52,008 (51.7%) |
51,784 (50.3%) |
52,774 (50.9%) |
54,038 (49.8%) |
| Prefràgil (5 - 8) |
28,826 (27.6%) |
29,377 (27.5%) |
30,002 (27.5%) |
30,105 (27.1%) |
32,095 (27.0%) |
36,344 (35.3%) |
36,411 (35.0%) |
36,490 (34.9%) |
36,127 (34.5%) |
37,729 (34.0%) |
| Fragilitat moderada (9 - 11) |
6,627 (6.5%) |
7,184 (6.9%) |
7,930 (7.5%) |
7,877 (7.3%) |
9,207 (7.8%) |
9,802 (9.1%) |
10,717 (9.9%) |
11,472 (10.6%) |
11,085 (10.3%) |
13,011 (11.1%) |
| Fragilitat severa (>12) |
1,830 (1.8%) |
2,472 (2.4%) |
2,989 (2.9%) |
3,101 (2.9%) |
4,113 (3.5%) |
2,992 (2.7%) |
3,762 (3.4%) |
4,616 (4.2%) |
4,591 (4.2%) |
6,108 (5.0%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
89,591 (58.4%) |
89,578 (57.2%) |
89,795 (55.9%) |
92,908 (56.9%) |
95,728 (55.9%) |
36,118 (52.0%) |
35,167 (49.9%) |
34,717 (48.3%) |
35,685 (49.0%) |
36,116 (47.6%) |
| Prefràgil (5 - 8) |
48,741 (31.5%) |
49,330 (31.5%) |
50,359 (31.6%) |
50,085 (31.0%) |
52,624 (30.6%) |
26,089 (35.4%) |
26,660 (36.0%) |
26,905 (36.2%) |
26,510 (35.5%) |
27,932 (35.5%) |
| Fragilitat moderada (9 - 11) |
12,278 (7.8%) |
13,389 (8.5%) |
14,339 (9.0%) |
14,176 (8.8%) |
16,536 (9.4%) |
7,418 (9.5%) |
8,009 (10.2%) |
8,407 (10.8%) |
8,288 (10.6%) |
9,496 (11.2%) |
| Fragilitat severa (>12) |
3,726 (2.3%) |
4,608 (2.9%) |
5,489 (3.4%) |
5,436 (3.4%) |
7,417 (4.1%) |
2,522 (3.1%) |
3,121 (3.9%) |
3,762 (4.7%) |
3,851 (4.8%) |
5,051 (5.7%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
19,674 (51.2%) |
19,306 (49.7%) |
19,023 (48.2%) |
19,408 (48.8%) |
19,679 (48.0%) |
| Prefràgil (5 - 8) |
15,793 (38.7%) |
15,956 (39.0%) |
16,125 (39.2%) |
15,862 (38.2%) |
16,518 (37.8%) |
| Fragilitat moderada (9 - 11) |
3,446 (8.0%) |
3,784 (8.8%) |
4,060 (9.5%) |
4,163 (9.6%) |
4,843 (10.2%) |
| Fragilitat severa (>12) |
898 (2.1%) |
1,107 (2.5%) |
1,352 (3.1%) |
1,458 (3.3%) |
1,950 (4.0%) |
Torna a dalt
